Voyageur Pharmaceuticals has advanced its Mueller iodine extraction process, achieving 99.8% iodine purity and over 90% recovery in lab tests using real oilfield brine. The company is preparing to begin field pilot testing in September 2026 with a mobile unit capable of processing 80,000 liters per day. This technology aims to create a domestic North American iodine supply for medical imaging, reduce reliance on imports, and add value to oilfield brine waste. Voyageur plans to scale up production to support its iodine-based pharmaceutical manufacturing strategy.
In Austria, selling Bitcoin directly between private individuals is taxed the same as sales via crypto exchanges. The taxable event is the capital gain—the difference between sale proceeds and acquisition cost—with a 27.5% tax rate for Bitcoin acquir...
The U.S. SEC has approved Evernorth's registration, clearing the way for its $1 billion Nasdaq listing under the ticker XRPN through a merger with Armada Acquisition Corp. II. Evernorth plans to actively manage its XRP treasury to generate yield and ...
Amprius Technologies is benefiting from strong demand for drone batteries, reporting a 125.7% year-over-year revenue increase and improved gross margins. The company raised its 2026 revenue forecast to at least $140 million and aims for $600 million ...
INmune Bio is considered significantly undervalued with its treatment Ebstrocel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) driving a strong investment case. Ebstrocel offers systemic itch reduction, setting it apart from competitors like K...
PayPal's stock dropped sharply by 14.67% to $52.45 after Stripe and Advent withdrew their $60.50 per share acquisition offer, causing the company's market value to fall from $52.58 billion to $44.87 billion. This reversal ended the summer rally drive...
